Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of an optimal lidocaine infusion strategy for neonatal seizures.
Malingré MM, Van Rooij LG, Rademaker CM, Toet MC, Ververs TF, van Kesteren C, de Vries LS. Malingré MM, et al. Among authors: van kesteren c, van rooij lg. Eur J Pediatr. 2006 Sep;165(9):598-604. doi: 10.1007/s00431-006-0136-x. Epub 2006 May 12. Eur J Pediatr. 2006. PMID: 16691409 Clinical Trial.
Once-daily intravenous busulfan with therapeutic drug monitoring compared to conventional oral busulfan improves survival and engraftment in children undergoing allogeneic stem cell transplantation.
Bartelink IH, Bredius RG, Ververs TT, Raphael MF, van Kesteren C, Bierings M, Rademaker CM, den Hartigh J, Uiterwaal CS, Zwaveling J, Boelens JJ. Bartelink IH, et al. Among authors: van kesteren c. Biol Blood Marrow Transplant. 2008 Jan;14(1):88-98. doi: 10.1016/j.bbmt.2007.09.015. Biol Blood Marrow Transplant. 2008. PMID: 18158965 Free article. Clinical Trial.
Population Pharmacokinetics of Fludarabine in Children and Adults during Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation.
Langenhorst JB, Dorlo TPC, van Maarseveen EM, Nierkens S, Kuball J, Boelens JJ, van Kesteren C, Huitema ADR. Langenhorst JB, et al. Among authors: van kesteren c, van maarseveen em. Clin Pharmacokinet. 2019 May;58(5):627-637. doi: 10.1007/s40262-018-0715-9. Clin Pharmacokinet. 2019. PMID: 30327943 Free PMC article.
Development and validation of limited sampling strategies for prediction of the systemic exposure to the novel anticancer agent E7070 (N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide).
van Kesteren C, Mathôt RA, Raymond E, Armand JP, Fumoleau P, Punt C, Ravic M, Wanders J, Beijnen JH, Schellens JH; Early Clinical Studies Group of the EORTC and NDDO Oncology. van Kesteren C, et al. Br J Clin Pharmacol. 2002 Nov;54(5):463-71. doi: 10.1046/j.1365-2125.2002.01684.x. Br J Clin Pharmacol. 2002. PMID: 12445024 Free PMC article. Clinical Trial.
Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome.
Admiraal R, Jol-van der Zijde CM, Furtado Silva JM, Knibbe CAJ, Lankester AC, Boelens JJ, Hale G, Etuk A, Wilson M, Adams S, Veys P, van Kesteren C, Bredius RGM. Admiraal R, et al. Among authors: van kesteren c. Clin Pharmacokinet. 2019 Dec;58(12):1609-1620. doi: 10.1007/s40262-019-00782-0. Clin Pharmacokinet. 2019. PMID: 31131436 Free PMC article.
51 results